Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
8,722,951
-
Share change
-
+49,116
-
Total reported value
-
$142,593,346
-
Put/Call ratio
-
91%
-
Price per share
-
$16.36
-
Number of holders
-
46
-
Value change
-
-$126,994
-
Number of buys
-
21
-
Number of sells
-
24
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2021
As of 30 Jun 2021 Profound Medical Corp. - Common Shares (PROF) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,722,951 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FIL Ltd, LETKO, BROSSEAU & ASSOCIATES INC, GAGNON SECURITIES LLC, Redmile Group, LLC, PURA VIDA INVESTMENTS, LLC, Blackcrane Capital, LLC, ROYCE & ASSOCIATES LP, AWM Investment Company, Inc., and Gagnon Advisors, LLC.
This table shows 46 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.